BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 8
• 9
• 10
• 11
• 12

• Press Releases

  DLH to Announce Fiscal 2026 First Quarter Financial Results

  February 2, 2026

   · 

  1 min read
• Press Releases

  Real-world head-to-head analysis shows 51% reduction in risk of death for patients with metastatic castration-sensitive prostate cancer treated with ERLEADA® (apalutamide) versus darolutamide without docetaxel through 24 months

  February 2, 2026

   · 

  17 min read
• Press Releases

  Exelixis Announces U.S. FDA Accepted the New Drug Application for Zanzalintinib in Combination with an Immune Checkpoint Inhibitor for Patients with Metastatic Colorectal Cancer

  February 2, 2026

   · 

  7 min read
• Press Releases

  GE HealthCare announces U.S. FDA 510(k) clearance and CE Mark for Allia Moveo and marks first global installation, advancing precision care in the interventional suite

  February 2, 2026

   · 

  6 min read
• Press Releases

  TempraMed Enters Strategic Media Partnership with Dr. Phil’s Envoy Media, Validating Product Portfolio and Accelerating Market Adoption Across the United States

  Access to an audience of over 19 million individuals monthly will expand national exposure, and supports scalable demand generation across B2C and B2B channels for TempraMed’s full product portfolio

  February 2, 2026

   · 

  6 min read
• Press Releases

  OS Therapies Initiates US FDA BLA Filing for OST-HER2 in the Prevention or Delay of Recurrent, Fully Resected, Pulmonary Metastatic Osteosarcoma

  February 2, 2026

   · 

  6 min read
• Press Releases

  Aires Enters Collaboration Agreement with Leading Wellness Expert Gary Brecka’s Brand, The Ultimate Human

  February 2, 2026

   · 

  6 min read
• Press Releases

  PharmaTher Launches Strategic Initiative to Pursue Health Canada Approval for Generic Semaglutide in Canada, Building on FDA-Approved Ketamine Success

  February 2, 2026

   · 

  4 min read
• Press Releases

  Theralase(R) Completes Enrollment in Bladder Cancer Clinical Study

  February 2, 2026

   · 

  7 min read
• Press Releases

  Dogwood Therapeutics Announces 50% Enrollment in Ongoing Halneuron® Phase 2b Trial, Top Line Results Anticipated in Q3 2026

  February 2, 2026

   · 

  5 min read